Psychiatry Research
Volume 133, Issue 2 , Pages 281-284 , 28 February 2005

Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment

  • Eugenia Rota

      Affiliations

    • Department of Neuroscience, University of Turin, Via Cherasco 15, Turin 10126, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 11 6636327, +39 11 6335423; fax: +39 11 6963487.
  • ,
  • Roberta Broda

      Affiliations

    • Department of Psychiatry, Amedeo Avogadro University, Novara, Italy
  • ,
  • Luigi Cangemi

      Affiliations

    • Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, Turin, Italy
  • ,
  • Giuseppe Migliaretti

      Affiliations

    • Department of Public Health and Microbiology, Statistical Unit, University of Turin, Turin, Italy
  • ,
  • Piero Paccotti

      Affiliations

    • Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
  • ,
  • Carlo Rosso

      Affiliations

    • Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, Turin, Italy
  • ,
  • Eugenio Torre

      Affiliations

    • Department of Psychiatry, Amedeo Avogadro University, Novara, Italy
  • ,
  • Patrizia Zeppegno

      Affiliations

    • Department of Psychiatry, Amedeo Avogadro University, Novara, Italy
  • ,
  • Paolo Portaleone

      Affiliations

    • Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, Turin, Italy

Received 15 September 2003 ,Accepted 22 December 2003.

References 

  1. Barden N, Reul JM, Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic–pituitary–adrenocortical system?. Trends in Neurosciences. 1995;18:6–11
  2. Heuser IJE, Schweiger U, Gotthardt U, Schmider J, Lammers CH, Dettling M, et al. Pituitary–adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. American Journal of Psychiatry. 1996;153:93–99
  3. Holsboer F. Neuroendocrinology of mood disorders. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 970–982
  4. Inder WJ, Prickett TCR, Mulder RT, Donald RA, Joyce PR. Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine. Psychopharmacology. 2001;156:73–78
  5. Linkowski P, Mendlewicz J, Leclercq R, Brasseur M, Hubain P, Golstein J, et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. Journal of Clinical Endocrinology and Metabolism. 1985;61(3):429–437
  6. O'Brien JT. The “glucocorticoid cascade” hypothesis in man. British Journal of Psychiatry. 1997;170:199–201
  7. Pfohl B, Sherman B, Schlechte J, Winokur G. Differences in plasma ACTH and cortisol between depressed patients and normal controls. Biological Psychiatry. 1985;20:1055–1071
  8. Wirz-Justice A. Biological rhythms in mood disorders. In:  Bloom FE,  Kupfer DJ editor. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press; 1995;p. 999–1018

PII: S0165-1781(04)00303-8

doi: 10.1016/j.psychres.2003.12.030

Psychiatry Research
Volume 133, Issue 2 , Pages 281-284 , 28 February 2005